Back to Newsroom
Back to Newsroom

Poko Innovations Debuts its Poko Skincare Range for PCOS Skin Concerns on Virgin Media’s Popular Ireland Breakfast Show Ireland AM

Wednesday, June 15, 2022 5:30 AM

LONDON / DUBLIN, UK / ACCESSWIRE / June 15, 2022 / (POKO:CSE): an award-winning UK-based collection of CBD-focused companies that bring innovative, inspiring solutions to the CBD industry through the company's leading platforms which, when working together, form a complete ecosystem, is delighted to have been featured on Ireland's only Irish breakfast talk show, Ireland AM. Pharmacist and brand ambassador, Jess Redden talked about PCOS, hormonal acne, and how to look after your skin with Poko's vegan and cruelty-free skincare range.

Ireland AM is the longest-running daytime show in Ireland featuring the latest news, lifestyle features, human interest, and consumer affairs presented by the Ireland AM team. Ireland AM airs weekdays from 7am to 10am and is the only Irish breakfast show on the air.

Poko Innovations Inc, Wednesday, June 15, 2022, Press release picture

The segment was presented by Tommy Bowe & Muireann O'Connell alongside Jess Redden and focused on the effects Polycystic Ovary Syndrome can have on your skin & overall health. Jess talked through the hero products in the Poko range for this condition, mainly our Purifying Gel Cleanser, Soothing Serum, Azelaic Acid & Daily SPF50 Moisturiser, and talked about their ingredients. She also touched on how diet and stress management can relieve PCOS symptoms - giving Canndid CBD gummies a mention as an aid to stress and anxiety management.

Polycystic Ovary Syndrome affects 1 in 10 women in Ireland and 1 in 5 women in the UK, making a common hormonal imbalance. According to pennmedicine, "It is estimated that between five to 10 percent of U.S. women of childbearing age have PCOS. That's about 5 million women, which makes the condition one of the most common hormonal endocrine disorders among women of reproductive age." Poko's aim is to provide long-term skin solutions to people with this condition and continue to build a following within the PCOS community.

The segment was met with positivity and an influx of messages from people seeking advice on how to use the products in relation to this condition. The Poko team have been diligently working through all queries and are looking forward to building lasting relationships within this community.

You can watch the segment here: Poko Skincare on Ireland AM

About The Poko Group, Ltd

The Poko Group is a collection of CBD-focused companies that bring innovative, inspiring solutions to the CBD industry through the company's leading platforms which, when working together, form a complete ecosystem. The Poko Group is an award-winning UK CBD company that has developed a unique business model comprising complete "turnkey solutions," including fintech payment processing and white label opportunities. Poko plans to export its signature products to the EU and the USA. For more information, please visit

Forward-Looking Statements

With the exception of the historical information contained in this news release, the matters described herein, may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Statements preceded by, followed by, or that otherwise, include the words "believes," "expects," "anticipates," "intends," "projects," "estimates," "plans" and similar expressions or future or conditional verbs such as "will," "should," "would," "may" and "could", are generally forward-looking in nature and not historical facts, although not all forward-looking statements include the foregoing. These statements, involve unknown risks and uncertainties that may individually or materially impact the matters discussed, herein for a variety of reasons that are outside the control of the company, including, but not limited to, the company's ability to raise sufficient financing to implement its business plan, the impact of the COVID-19 pandemic on the company's business, operations and the economy in general, and the Company's ability to successfully develop and commercialize its proprietary products and technologies. Readers are cautioned not to place undue reliance on these forward-looking statements, as actual results could differ materially from those described in the forward-looking statements contained herein. Readers are urged to read the risk factors set forth in the company's filings with the SEC, which are available at the SEC's website ( The company disclaims any intention or obligation to update, or revise, any forward-looking statements, whether as a result of new information, future events or otherwise.

Investor Relations
Michael J. Porter, President
Porter, LeVay & Rose, Inc.
T: (973) 865-9357
E: [email protected]

SOURCE: Poko Innovations Inc

Product Announcements
Back to newsroom
Back to Newsroom